Nuclear Medicine Recent Articles

Nuclear Medicine Recent Articles:

March 2016:

Solitary pulmonary nodule and 18F-FDG PET/CT. Part 1: epidemiology, morphological evaluation and cancer probability. Radiol Bras 2016

January 2016:

MIBG in Neuroblastoma Diagnostic Imaging and Therapy. RadioGraphics 2016

Integrated 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging (18F-FDG PET/MRI), a multimodality approach for comprehensive evaluation of dementia patients: IJRI 2015

Emerging clinical applications of PET based molecular imaging in oncology: the promising future potential for evolving personalized cancer care. IJRI 2015

November 2015:

PET studies in epilepsy American journal of nuclear medicine and molecular imaging, January 2015

October 2015:

Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings. AJR 2015

Impact of 18F-FDG PET/CT on the staging and management of follicular lymphoma. Br J Radiol 2014

September 2015:

Diffusion-weighted and PET/MR Imaging after Radiation Therapy for Malignant Head and Neck Tumors. RadioGraphics 2015

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques. Korean J Radiol 2015

Gastrointestinal Motility, Part 2: Small-Bowel and Colon Transit. JNM 2015

The Role of Nuclear Medicine in Malignant Melanoma. Journal of Nuclear Medicine & Radiation Therapy 2015

August 2015:

Gastrointestinal Motility, Part 1: Esophageal Transit and Gastric Emptying. JNM 2015

Contemporary approaches for imaging skeletal metastasis. Bone Res 2015

Non-cutaneous melanoma: is there a role for 18F-FDG PET-CT? Br J Radiol 2014

July 2015:

FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity. AJR 2015

Spectrum of Physiologic and Pathologic Skeletal Muscle 18F-FDG Uptake on PET/CT. AJR 2015

18F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis. AJR 2015

All You Need to Know as an Authorized User. AJR 2015

The importance of PET/CT in the evaluation of patients with Ewing tumors. Radiol Bras 2015

June 2015:

PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases Quant Imaging Med Surg 2015

Lymphoscintigraphy and Sentinel Nodes JNM 2015

May 2015:

Imaging of prostate cancer with PET/CT using 18F-Fluorocholine Am J Nucl Med Mol Imaging 2015

Spondylolysis and Beyond: Value of SPECT/CT in Evaluation of Low Back Pain in Children and Young Adults RadioGraphics 2015

Appropriateness criteria of FDG PET/CT in oncology. Indian J Radiol Imaging 2015

Applied hepatobiliary scintigraphy in acute cholecystitis Applied Radiology 2015

April 2015:

Radiosynovectomy in the Therapeutic Management of Arthritis. World J Nucl Med 2015

Somatostatin Receptor Based Imaging and Radionuclide Therapy. Biomed Res Int 2015

Approaches to Reducing Radiation Dose from Radionuclide Myocardial Perfusion Imaging. JNM 2015

How to Write a Protocol: Part 1 JNMT 2015

How to Write a Protocol: Part 2 JNMT 2015

March 2015:

Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers. Digestive and Liver Disease 2015.

Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation RadioGraphics 2015

Cancer Immunotherapy: Imaging Assessment of Novel Treatment Response Patterns and Immune-related Adverse Events RadioGraphics 2015

Amyloid PET imaging: applications beyond Alzheimer’s disease Clin Transl Imaging 2015

Beta-amyloid imaging with florbetaben Clin Transl Imaging 2015

February 2015:

The sweet spot: FDG and other 2-carbon glucose analogs for multi-modal metabolic imaging of tumor metabolism Am J Nucl Med Mol Imaging 2015

Advances in Pinhole and Multi-Pinhole Collimators for Single Photon Emission Computed Tomography Imaging World J Nucl Med 2015

The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 1 AJNR 2015

The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 2 AJNR 2015

Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies JNM 2015

Potential role of 18F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy Indian J Nucl Med 2015

State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment. J Gastrointest Oncol 2015

January 2015:

Integrated Whole Body MR/PET: Where Are We? Korean J Radiol 2015

Update on Time-of-Flight PET Imaging JNM 2015

Clinical and research applications of simultaneous positron emission tomography and MRI Br J Radiol 2014

Brain FDG PET and the Diagnosis of Dementia AJR 2015

December 2014:

PET Approaches for Diagnosis of Dementia AJNR 2014

SPECT-CT: applications in musculoskeletal radiology Br J Radiol 2013

FDG PET/CT in the Management of Colorectal and Anal Cancers AJR 2014

Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors JNM 2014

November 2014:

Assessment Lumboperitoneal or Ventriculoperitoneal Shunt Patency by Radionuclide Technique World J Nucl Med 2014

Post-treatment appearances, pitfalls, and patterns of failure in head and neck cancer on FDG PET/CT imaging Indian J Nucl Med 2014

Structural and Functional Imaging in Parkinsonian Syndromes RadioGraphics 2014

Newer PET Application with an Old Tracer: Role of 18F-NaF Skeletal PET/CT in Oncologic Practice RadioGraphics 2014

Radioiodine Therapy for Thyroid Cancer in the Era of Risk Stratification and Alternative Targeted Therapies JNM 2014

October 2014:

Clinical applications of PET/MRI: current status and future perspectives Diagnostic and Interventional Radiology 2014

SNMMI and EANM Practice Guideline for Meckel Diverticulum Scintigraphy 2.0 JNMT 2014